Abbott’s New Two-in-One CGM Measures Glucose and Ketones—But the Data Could Complicate Diabetes Management
The Libre Duo, recently authorized by the FDA, is the first continuous glucose monitor to also track ketone levels. While it could help prevent diabetic ketoacidosis, experts warn that interpreting continuous ketone data remains a challenge, and early adoption may be rocky.